ChungJ.TakeshitaJ.ShinDB.HaynesK.ArnoldSE.GelfandJ. The Risk of Parkinson’s Disease in Patients with Psoriasis: A Population-based Cohort Study. Presented at the Annual Meeting of the Society for Investigative Dermatology, Atlanta, GA; 6-9. 2015
2.
SheuJ-J.WangK-H.LinH-C.HuangC-C. Psoriasis is associated with an increased risk of parkinsonism: a population-based 5-year follow-up study. J Am Acad Dermatol. 2013;68(6):992-999.doi:10.1016/j.jaad.2012.12.96123374233
3.
BaranA.NowowiejskaJ.HermanowiczJMet al. The potential role of serum tau protein (MAPT), neuronal cell adhesion molecule (NrCAM) and neprilysin (NEP) in neurodegenerative disorders development in Psoriasis-Preliminary results. J Clin Med. 2022;11(17):5044.doi:10.3390/jcm1117504436078974
4.
LeeJH.HanK.GeeHY. The incidence rates and risk factors of Parkinson disease in patients with psoriasis: a nationwide population-based cohort study. J Am Acad Dermatol. 2020;83(6):1688-1695.doi:10.1016/j.jaad.2019.07.01231302182
5.
UngprasertP.SrivaliN.KittanamongkolchaiW. Risk of Parkinson’s disease among patients with psoriasis: a systematic review and meta-analysis. Indian J Dermatol. 2016;61(2):152-156.doi:10.4103/0019-5154.17777127057013
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
